Integration of Neurocognitive Biomarkers Into a Neuro-Oncology Clinic

This is prospective observational registry study that will assess 1) if the neurocognitive function app (Brainlab Cognition) can be used in a widespread neuro-oncology clinic setting and 2) if patient reported quality of life parameters can be obtained electronically and integrated into clinic.

NCT Number	NCT05504681
Lead Sponsor	Baptist Health South Florida Collaborators: Brainlab AG
Conditions	Neurocognitive Disorders
Enrollment	200 participants
Start Date	2021-11-30
Primary Completion	2030-04 (estimated)
Study Completion	2032-04 (estimated)
Updated on ClinicalTrials.gov	2026-05-19